US 11959081
Transthyretin (TTR) iRNA compositions and methods of use thereof
granted A61KA61K31/713
Quick answer
US patent 11959081 (Transthyretin (TTR) iRNA compositions and methods of use thereof) held by Alnylam Pharmaceuticals, Inc. expires Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Apr 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K31/713